View in EDS PDF Full Text

CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.

Saved in:
Bibliographic Details
Title: CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.
Authors: Zhou S, Xu X, Cuo J, Sun C, Hou Y, Wang X, Nana D, Weixun S
Source: Clinical laboratory [Clin Lab] 2026 May 01; Vol. 72 (5).
Publication Type: Journal Article
Journal Info: Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42159124
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhou+S%22">Zhou S</searchLink><br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink><br /><searchLink fieldCode="AU" term="%22Cuo+J%22">Cuo J</searchLink><br /><searchLink fieldCode="AU" term="%22Sun+C%22">Sun C</searchLink><br /><searchLink fieldCode="AU" term="%22Hou+Y%22">Hou Y</searchLink><br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink><br /><searchLink fieldCode="AU" term="%22Nana+D%22">Nana D</searchLink><br /><searchLink fieldCode="AU" term="%22Weixun+S%22">Weixun S</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229705611%22">Clinical laboratory</searchLink> [Clin Lab] 2026 May 01; Vol. 72 (5).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clinical+Laboratory+Publications%22">Clinical Laboratory Publications </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9705611 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1433-6510 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214336510%22">14336510 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42159124
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7754/Clin.Lab.2025.250744
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou S
      – PersonEntity:
          Name:
            NameFull: Xu X
      – PersonEntity:
          Name:
            NameFull: Cuo J
      – PersonEntity:
          Name:
            NameFull: Sun C
      – PersonEntity:
          Name:
            NameFull: Hou Y
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Nana D
      – PersonEntity:
          Name:
            NameFull: Weixun S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1433-6510
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical laboratory
              Type: main
ResultId 1